JMJD1A promotes the transcription of PGK1 by regulating H3K9me2 levels in the PGK1 promoter region and interacting with HIF-1α to regulate the glucose metabolism pathway in bladder cancer cells, thus regulating the progression of bladder carcinoma. Here, KDM3A is linked to urinary bladder carcinoma.